A substantial proportion of cancer in each country can be prevented by implementing resource-stratified cancer prevention and control measures,” said Ahmedin Jemal, DVM, PhD.

There were no cases of HER2 positivity among patients with gliomas, sarcomas, small cell lung cancer, gastrointestinal stromal tumors, thyroid carcinoma, uterine sarcoma, thymic carcinoma, and Merkel ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for ...

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

Research presented at ASCO 2025 highlighted potential treatments for patients with newly diagnosed and relapsed or refractory ...

Lymphoma research presented at ASCO 2025 highlighted investigational treatments for FL, HL, and DLBCL as well as a revised ...

But health policy analysts say prior authorization — a system that forces some people to delay care or abandon treatment — may continue to pose serious health consequences for affected patients. That ...

Preoperative stereotactic radiation therapy (SRT) could expedite treatment for cancer patients with brain metastases and is as safe as postoperative SRT, according to preliminary findings published in ...

Roughly half of patients had sustained reductions in depression and anxiety up to 2 years after receiving psilocybin and psychotherapy.

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for chemotherapy in certain patients with NSCLC.

Omitting carboplatin from neoadjuvant treatment can improve safety without compromising efficacy in patients with HER2-positive early breast cancer.